Testicular Cancer: Diagnosis and Treatment

When a man is diagnosed with testicular cancer, the first thing that comes to mind is death in his mind. Later, sadness, despair, and denial were the most common reactions between him and his entire family. As the disease was further investigated, several problems occurred with regard to disease and treatment. But this is just the beginning of a long journey to overcome the disease. As part of a difficult process, the important decision is to choose whether or not to undergo orchiectomy. Orchiectomy is an operation that resects one or two testes and is most commonly used for the treatment of testicular cancer.

With timely diagnosis, testicular cancer can be treated and usually has the potential to cure. It is the most common cancer among males between the ages of 15 and 34 years. However, this situation is very rare. This year, 9,310 men in the United States are diagnosed with testicular cancer. The risk of death from testicular cancer is small. About 400 men in the United States died of testicular cancer this year. Testes (also called testis or testes) are part of the male reproductive system. The glands of these two golf sizes are held in the capsule under the penis (scrotum). The testes are hard and have a slightly spongy feel. At the upper and outer edges there is a rubbery tubular structure called the epididymis. The hardness of the testes should be consistent. The size of the testicles should also be about the same

Every year, thousands of men and women are diagnosed with prostate cancer, bladder cancer, kidney cancer, and testicular cancer. A new breakthrough in cancer treatment, experimental treatment options, and ongoing research on etiology and potential treatment of urological malignancies has brought new hope for patients in every step of their lives. University of California Los Angeles Urology Oncology Institute is seeking to unite interdisciplinary scientists and doctor teams as part of a multidisciplinary organization to independently operate in the traditional academic department. Their goal is to accelerate the development of new treatments for urogenital cancer patients. Professor of urology at the University of California, Los Angeles, Director of Research Institute, Dr. Ally Verdegun, said: Johnson General Cancer Center Researcher